LSV Asset Management
IPXL

LSV Asset Management’s Impax Laboratories, Inc. IPXL Stock Holding History

LSV Asset Management’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-10,500
Closed -$213K – 1022
2017
Q3 		$213K Hold
10,500
– – ﹤0.01% 933
2017
Q2 		$169K Sell
10,500
-13,600
-56% -$201K ﹤0.01% 951
2017
Q1 		$304K Hold
24,100
– – ﹤0.01% 906
2016
Q4 		$319K Buy
+24,100
New +$412K ﹤0.01% 897

Other funds holding IPXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TG
TCW Group Los Angeles, California $14.9B AUM 46.29% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

LSV Asset Management's IPXL Position: Q4 2017 in Review

LSV Asset Management sold out of Impax Laboratories, Inc. (IPXL) in Q4 2017, closing a stake of 10,500 shares — an estimated $213K sold.

LSV Asset Management first reported a position in IPXL in Q4 2016 and held it in 4 quarters. The position peaked at $319K in Q4 2016. 200 funds tracked by Wall St. Rank hold IPXL as of Q4 2017.

  • LSV Asset Management reported no remaining Impax Laboratories, Inc. position as of Q4 2017 after selling out during the quarter.
  • LSV Asset Management sold 10,500 Impax Laboratories, Inc. shares in Q4 2017, an estimated $213K.
  • LSV Asset Management first reported a position in Impax Laboratories, Inc. in Q4 2016 and held it in 4 quarters.
  • LSV Asset Management's Impax Laboratories, Inc. position peaked at $319K in Q4 2016.
  • 200 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2017.

Based on LSV Asset Management's 13F filing for Q4 2017, filed 1 Feb 2018.